|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: FOUNTAIN PHARMACEUTICALS INC, 10QSB, 2000-07-31 |
Next: FIRST TRUST COMBINED SERIES 82, 485BPOS, 2000-07-31 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF FOUNTAIN PHARMACEUTICALS, INC. FOR THE NINE MONTHS ENDED
JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER>1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-START> OCT-01-1999
<PERIOD-END> JUN-30-2000
<CASH> 210
<SECURITIES> 0
<RECEIVABLES> 49
<ALLOWANCES> (10)
<INVENTORY> 375
<CURRENT-ASSETS> 642
<PP&E> 441
<DEPRECIATION> (330)
<TOTAL-ASSETS> 904
<CURRENT-LIABILITIES> 2,801
<BONDS> 0
0
2
<COMMON> 2
<OTHER-SE> (1,920)
<TOTAL-LIABILITY-AND-EQUITY> 904
<SALES> 929
<TOTAL-REVENUES> 929
<CGS> 128
<TOTAL-COSTS> 1,665
<OTHER-EXPENSES> 11
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 172
<INCOME-PRETAX> (1,047)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,047)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,047)
<EPS-BASIC> (0.44)
<EPS-DILUTED> 0
</TABLE>
|
|